AtlanChim Pharma was created in January 2004 and purchased by the company Atlantic Bone Screen in April 2008. The company developed an acknowledged know-how in the field of fine organic chemistry to the laboratory scale. 

Two academic researchers with a great experience in the chemistry project management are behind the company. They accumulate several dozens of years spent in contact with research in pharmaceutical industry, at CNRS (Centre for National Scientific Research) and at University and bring the whole experience of their work to the company AtlanChim Pharma .

•Professor Jacques Lebreton is both Scientific Director at AtlanChim Pharma and Professor at University. (more)

+33(0)2 51 12 54 03 +33(0)6 35 30 32 90

jacques.lebreton@atlanchimpharma.com

•Doctor André Guingant is both Scientific Director and Research Director to the CNRS. (more)

+33(0)2 51 12 54 13 – +33(0)6 35 30 32 72

andre.guingant@atlanchimpharma.com

AtlanChim Pharma and Atlantic Bone Screen , Biotechnology Company focusing on biological evaluation of compounds in phase of development, form the ideal partner in the field of therapeutic chemistry for the conception and the evaluation of your compounds, in accordance with your specifications.